RFP
Closed:

P-selectin antagonist Bicycles: a Novel Chemical Modality to Explore the Role of P-selectin in Disease

BicycleTx Ltd. (Bicycle®) has developed an extensive library of small molecule peptidic compounds called ‘Bicycles’, which are constrained bicyclic peptides that bind with high affinity and selectivity to targets. Bicycles combine the pharmacological properties characteristic of biologics with the manufacturing and pharmacokinetic advantages of small molecules. Bicycle® is seeking to establish research collaborations to fully characterise these tools, and explore their potential application across different therapeutics areas with a disease area agnostic...

Responses:

  • Applicants must use the submission template (provided upon registration) when preparing a response outlining a research project proposal

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Responses:

  • Applicants must use the submission template (provided upon registration) when preparing a response outlining a research project proposal
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.